Thymol

Thymol

SCHEMBL1867982

Cc1ccc(C(C)C)c(O)c1.Cc1ccc(C(C)C)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 1.00
TRPA1 O75762 2/20 1.00
SLC6A2 P23975 2/20 1.00
HTR2B P41595 2/20 1.00
CHRM1 P11229 1/20 1.00
ADRA1A P35348 1/20 1.00
SRC P12931 1/20 0.51
GABRA1 P14867 2/20 0.50
GABRB2 P47870 2/20 0.50
ALDH1A1 P00352 2/20 0.46
TP53 P04637 2/20 0.46
GAA P10253 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
ALOX15 P16050 2/20 0.43
HSD17B10 Q99714 2/20 0.43
HPGD P15428 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymol SCHEMBL30332213 1.00 LMNA (1.00) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL29579824 1.00 LMNA (1.00) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL22165 1.00 LMNA (1.00) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL4729745 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL1668335 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL23932298 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL7074408 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL8506977 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL5905814 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1
Thymol SCHEMBL5034474 0.98 LMNA (0.95) LMNATRPA1SLC6A2HTR2BCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108379087-A Filling paste for dental pulp conservation treatment and preparation method thereof 徐崇明 2018-08-10 CN claimed
US-9241886-B2 Dye composition using a particular phenolic coupler in a medium rich in fatty substances, processes and devices L'OREAL (FR) 2016-01-26 US claimed
US-20140053346-A1 DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES L'OREAL (FR) 2014-02-27 US claimed
US-20100212181-A1 METHODS FOR TREATING FABRIC IN A DRYER THE DIAL CORPORATION (US) 2010-08-26 US claimed
US-11400050-B2 Method for the production of a dosage form OMYA INTERNATIONAL AG (CH) 2022-08-02 US disclosed
CN-110101732-B Chrysanthemum stem leaf multi-component granules with function of improving intestinal tract and preparation method and application thereof 南京中医药大学 2022-03-11 CN disclosed
CN-108697629-B Natural substituted plant essential oil preservative and application thereof in cosmetics 拉芳家化股份有限公司 2021-10-15 CN disclosed
US-11062794-B2 Olfactory signature and odorant mixture having the same YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-07-13 US disclosed
US-20190328668-A1 METHOD FOR THE PRODUCTION OF A DOSAGE FORM OMYA INTERNATIONAL AG (CH) 2019-10-31 US disclosed
US-10448643-B2 Low pH disinfectant composition MEDIVATORS INC. (US) 2019-10-22 US disclosed
CN-110101732-A With the chrysanthemum cauline leaf multicomponent granule and the preparation method and application thereof for improving function of intestinal canal 南京中医药大学 2019-08-09 CN disclosed
EP-3493674-A2 ANTIMICROBIAL COMPOSITION Firmenich SA (CH) 2019-06-12 EP disclosed
EP-1032264-A1 METHOD OF ENHANCING THE ANTIMICROBIAL PROPERTIES OF ANTIBACTERIAL ANTIBIOTICS Badaway, Mohammed A. (US) 2000-09-06 EP disclosed
WO-2000010390-A1 METHOD OF ENHANCING THE ANTIMICROBIAL PROPERTIES OF ANTIBACTERIAL ANTIBIOTICS BADAWAY MOHAMMED A (US) 2000-03-02 WO disclosed
US-5916566-A Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds AVMAX, INC. (US) 1999-06-29 US disclosed
EP-0912678-A1 ANTIMICROBIAL CLEANING COMPOSITIONS CONTAINING AROMATIC ALCOHOLS OR PHENOLS UNILEVER PLC (GB) 1999-05-06 EP disclosed
US-5716928-A ADMINISTERING DRUG CONCURRENTLY WITH ESSENTIAL OIL AVMAX, INC. (US) 1998-02-10 US disclosed
WO-1998001524-A1 ANTIMICROBIAL CLEANING COMPOSITIONS CONTAINING AROMATIC ALCOHOLS OR PHENOLS UNILEVER PLC (GB) 1998-01-15 WO disclosed
US-5665386-A Use of essential oils to increase bioavailability of oral pharmaceutical compounds AVMAX, INC. (US) 1997-09-09 US disclosed
WO-1992018091-A1 ANTIMICROBIAL ORAL COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1992-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10448643-B2 Low pH disinfectant composition ADH1C, ADH1A, ADH5 LMNA 2816/4885TRPA1 1892/4885SLC6A2 4495/4885
US-20140053346-A1 DYE COMPOSITION USING A PARTICULAR PHENOLIC COUPLER IN A MEDIUM RICH IN FATTY SUBSTANCES, PROCESSES AND DEVICES C1R, F12, AKR1C3 LMNA 716/4885TRPA1 365/4885SLC6A2 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.